MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73

被引:35
|
作者
Xie, Minghao [1 ,2 ,3 ]
Qin, Huabo [1 ,2 ]
Luo, Qianxin [1 ,2 ]
Huang, Qunsheng [1 ,2 ]
He, Xiaosheng [1 ,2 ]
Yang, Zihuan [2 ,4 ]
Lan, Ping [1 ,2 ]
Lian, Lei [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Guangdong, Peoples R China
[3] Jiujiang Univ, Dept Gen Surg, Affiliated Hosp, Jiujiang 332000, Jiangxi, Peoples R China
[4] Sun Yat Sen Univ, Guangdong Inst Gastroenterol, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
MiR-30a; Colorectal cancer; Proliferation; Apoptosis; CD73; POOR-PROGNOSIS; EXPRESSION; MIR30A; RNAS;
D O I
10.1186/s12885-017-3291-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: MicroRNAs are non-coding RNAs which regulate a variety of cellular functions in the development of tumors. Among the numerous microRNAs, microRNA-30a (miR-30a) is thought to play an important role in the processes of various human tumors. In this study, we aimed to explore the role of miR-30a in the process of colorectal cancer (CRC). Methods: The quantitative real-time PCR and western blot analysis were used to detect the expressions of miR-30a and CD73 in CRC cell lines and clinical tissues. The luciferase reporter assay was conducted to validate the association between miR-30a and CD73. The CCK-8, terminal deoxynucleotidyl transferase dUTP -biotin nick end labeling (TUNEL) assays and cell cycle flow cytometry were carried out to verify the biological functions of miR-30a in vitro. The nude mouse tumorigenicity experiment was used to clarify the biological role of miR-30a in vivo. Results: The expression of miR-30a was significantly reduced in tumor cells and tissues of CRC. The proliferation ability of CRC cells was suppressed and the apoptosis of cells was promoted when miR-30a is over-regulated, however, the biological effects would be inverse since the miR-30a is down-regulated. CD73 is thought to be a target binding gene of miR-30a because miR-30a can bind directly to the 3'-UTR of CD73 mRNA, subsequently reducing its expression. The proliferation suppression of the CRC cells mediated by miR-30a could be rescued after up-regulating the expression of CD73. Conclusions: MiR-30a plays an important role on regulating the cell proliferation and apoptosis, thus affecting the growth of the tumor in CRC. And it may participate in the disease process of CRC by regulating the expression of CD73.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73
    Minghao Xie
    Huabo Qin
    Qianxin Luo
    Qunsheng Huang
    Xiaosheng He
    Zihuan Yang
    Ping Lan
    Lei Lian
    BMC Cancer, 17
  • [2] microRNA-30a Suppresses Cell Proliferation and Tumor Growth of Colorectal Carcinoma by Targeting CD73
    Xie, Minghao
    He, Xiaosheng
    Luo, Qianxin
    Qin, Huabo
    Yang, Zi-Huan
    Lan, Ping
    Lian, Lei
    GASTROENTEROLOGY, 2015, 148 (04) : S360 - S360
  • [3] MicroRNA-30a Mediates Cell Migration and Invasion by Targeting Metadherin in Colorectal Cancer
    Jin, Huifang
    Shi, Xiaoqing
    Zhao, Yanteng
    Peng, Mengle
    Kong, Yongkui
    Qin, Dongchun
    Lv, Xianping
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [4] MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin
    Zhang, N.
    Wang, X.
    Huo, Q.
    Sun, M.
    Cai, C.
    Liu, Z.
    Hu, G.
    Yang, Q.
    ONCOGENE, 2014, 33 (24) : 3119 - 3128
  • [5] MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin
    N Zhang
    X Wang
    Q Huo
    M Sun
    C Cai
    Z Liu
    G Hu
    Q Yang
    Oncogene, 2014, 33 : 3119 - 3128
  • [6] Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro
    Wu, Ruimin
    Chen, Yijia
    Li, Fuyan
    Li, Wei
    Zhou, Hong
    Yang, Yi
    Pei, Zhijun
    ONCOLOGY REPORTS, 2016, 35 (03) : 1750 - 1756
  • [7] Targeting CD73 to improves tumor immunotherapy
    Zhang, Bin
    Jin, Dachuan
    Fan, Jie
    Wang, Long
    Thompson, Linda
    Liu, Aijie
    Daniel, Ben
    Shin, Tahiro
    Curiel, Tyler
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [8] Targeting CD73 to augment cancer immunotherapy
    Roh, Meejeon
    Wainwright, Derek A.
    Wu, Jennifer D.
    Wan, Yong
    Zhang, Bin
    CURRENT OPINION IN PHARMACOLOGY, 2020, 53 : 66 - 76
  • [9] CD73 promotes tumor growth and metastasis
    Zhang, Bin
    ONCOIMMUNOLOGY, 2012, 1 (01): : 67 - 70
  • [10] Targeting CD73 in the tumor microenvironment with MEDI9447
    Hay, Carl M.
    Sult, Erin
    Huang, Qihui
    Mulgrew, Kathy
    Fuhrmann, Stacy R.
    McGlinchey, Kelly A.
    Hammond, Scott A.
    Rothstein, Raymond
    Rios-Doria, Jonathan
    Poon, Edmund
    Holoweckyj, Nick
    Durham, Nicholas M.
    Leow, Ching Ching
    Diedrich, Gundo
    Damschroder, Melissa
    Herbst, Ronald
    Hollingsworth, Robert E.
    Sachsenmeier, Kris F.
    ONCOIMMUNOLOGY, 2016, 5 (08):